Investment Research & Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-642
| Closed | -$82.1K | – | 260 |
|
|
2025
Q1 | $82.1K | Hold |
642
| – | – | 0.03% | 99 |
|
|
2024
Q4 | $84.9K | Hold |
642
| – | – | 0.04% | 94 |
|
|
2024
Q3 | $93.5K | Hold |
642
| – | – | 0.04% | 85 |
|
|
2024
Q2 | $88.1K | Hold |
642
| – | – | 0.04% | 82 |
|
|
2024
Q1 | $88.1K | Hold |
642
| – | – | 0.04% | 84 |
|
|
2023
Q4 | $87.2K | Hold |
642
| – | – | 0.04% | 84 |
|
|
2023
Q3 | $78.5K | Hold |
642
| – | – | 0.04% | 84 |
|
|
2023
Q2 | $81.5K | Hold |
642
| – | – | 0.05% | 84 |
|
|
2023
Q1 | $82.9K | Hold |
642
| – | – | 0.05% | 81 |
|
|
2022
Q4 | $84.3K | Hold |
642
| – | – | 0.06% | 80 |
|
|
2022
Q3 | $75K | Hold |
642
| – | – | 0.06% | 85 |
|
|
2022
Q2 | $76K | Hold |
642
| – | – | 0.06% | 88 |
|
|
2022
Q1 | $84K | Hold |
642
| – | – | 0.05% | 95 |
|
|
2021
Q4 | $98K | Hold |
642
| – | – | 0.06% | 82 |
|
|
2021
Q3 | $104K | Hold |
642
| – | – | 0.07% | 79 |
|
|
2021
Q2 | $105K | Hold |
642
| – | – | 0.07% | 84 |
|
|
2021
Q1 | $97K | Hold |
642
| – | – | 0.07% | 75 |
|
|
2020
Q4 | $97K | Hold |
642
| – | – | 0.07% | 75 |
|
|
2020
Q3 | $87K | Hold |
642
| – | – | 0.07% | 75 |
|
|
2020
Q2 | $87K | Hold |
642
| – | – | 0.08% | 71 |
|
|
2020
Q1 | $69K | Hold |
642
| – | – | 0.06% | 77 |
|
|
2019
Q4 | $77K | Buy |
+642
| New | +$77K | 0.07% | 85 |
|